Is XenoPort, Inc. (XNPT) Going to Burn These Hedge Funds?
At the moment, there are plenty of metrics market participants can use to monitor the equity markets. A pair of the most underrated are hedge fund and insider trading activity.
3Sbio Inc (SSRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Stevens Capital Management Matthew Tewksbury | 0 | $0 | 0% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% | |
| 3. | Sectoral Asset Management Jerome Pfund And Michael Sjostrom | 0 | $0 | 0% | |
| 4. | OrbiMed Advisors Samuel Isaly | 0 | $0 | 0% | |
| 5. | D E Shaw D. E. Shaw | 0 | $0 | 0% |
News See All
XenoPort, Inc. (XNPT): Hedge Funds and Insiders Are Bearish, What Should You Do?
Is XenoPort, Inc. (NASDAQ:XNPT) a healthy stock for your portfolio? Money managers are in a pessimistic mood.
Do Hedge Funds and Insiders Love AVEO Pharmaceuticals, Inc. (AVEO)?
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was in 9 hedge funds' portfolio at the end of the first quarter of 2013.
Should You Avoid Vical Incorporated (VICL)?
To the average investor, there are tons of indicators market participants can use to track their holdings. Two of the most under-the-radar are hedge fund and insider trading sentiment.
Should You Buy 3SBio Inc. (ADR) (SSRX)?
In today’s marketplace, there are plenty of gauges market participants can use to watch Mr. Market. Two of the most under-the-radar are hedge fund and insider trading interest.
Hedge Funds Are Betting On AVEO Pharmaceuticals, Inc. (AVEO)
To the average investor, there are plenty of indicators investors can use to monitor their holdings. Two of the most under-the-radar are hedge fund and insider trading interest.
Should You Buy AVEO Pharmaceuticals, Inc. (AVEO)?
To most shareholders, hedge funds are assumed to be unimportant, outdated investment tools of yesteryear.
3SBio Inc. (ADR) (SSRX): Insiders Are Dumping, Should You? - Vical Incorporated (VICL), Osiris Therapeutics, Inc. (OSIR)
3SBio Inc. (ADR) (NASDAQ:SSRX) was in 9 hedge funds' portfolio at the end of December. SSRX has seen an increase in hedge fund interest recently.